The Radiological Society of North America’s Annual Meeting returns to Chicago this year as RSNA 2025: Imaging the Individual, the 111th Scientific Assembly and the world’s leading annual radiology forum. From November 30 to December 4, 2025, more than 40,000 imaging professionals and industry leaders are expected at McCormick Place to explore how radiology is moving toward truly personalized, inclusive care.
The 2025 theme, “Imaging the Individual,” puts precision medicine and health equity at the center. RSNA highlights how innovations such as AI and visual language models, photon‑counting CT, sustainable imaging practices, and workforce well‑being are reshaping radiology. For vendors and innovators across imaging, MedTech, and digital health, RSNA 2025 is not only a scientific meeting—it is a live barometer of market momentum, adoption challenges, and emerging growth opportunities.
At Marketstrat, we see RSNA as one of the most important annual checkpoints for our work in medical imaging and MedTech commercialization across the Markintel Horizon and Markintel Pulse programs. Below is how we’re framing RSNA 2025 and what you can expect from our coverage.
RSNA 2025 at a glance
A few anchor points for this year’s meeting:
- Theme: RSNA 2025: Imaging the Individual – exploring new frontiers in precision medicine and inclusivity.
- Dates & location: November 30 – December 4, 2025, at McCormick Place, Chicago.
- Scale: More than 2,000 scientific presentations and posters, spanning Alzheimer’s disease, stroke, cancer, cardiovascular disease, obesity, and the latest AI advances.
- Technical Exhibits: Over 660–700+ exhibitors across 400,000+ square feet, including a dedicated AI Showcase with more than 100 companies and 228 exhibitors demonstrating AI and machine‑learning tools.
- Audience: A global, senior‑skewing attendee base of radiologists, imaging leaders, MedTech executives, and digital health innovators from 130+ countries.
For imaging, AI, and MedTech companies, RSNA 2025 is where product roadmaps, regulatory and reimbursement signals, and go‑to‑market narratives are stress‑tested in real time.
Why RSNA 2025 matters for MedTech, imaging, and AI leaders
From Marketstrat’s vantage point, RSNA 2025 is pivotal for three reasons:
- AI is moving from point solutions to infrastructure.
With more than 200 AI exhibitors and a substantial AI Showcase presence, RSNA 2025 reflects AI’s shift from isolated tools to integrated platforms, workflows, and operating infrastructure for radiology. - New hardware and theranostic capabilities are redefining baselines.
Advances such as photon‑counting CT, next‑generation MR, and hybrid modalities are redefining what “standard of care” could look like for stroke, oncology, and cardiology imaging. Vendors need to understand how these shifts will influence installed base strategies, capital budgets, and upgrade cycles. - Workforce, workflow, and sustainability are now board‑level topics.
RSNA’s focus on workforce well‑being, sustainable imaging practices, and health equity signals that buyer priorities are expanding beyond pure performance to include staffing, burnout, environmental footprint, and access.
Together, these dynamics make RSNA 2025 a critical moment for revisiting where to play, how to win, and how fast to move across imaging and imaging‑adjacent markets.
What Marketstrat will be watching at RSNA 2025
Throughout the meeting, Marketstrat will follow RSNA programming, news, and exhibitor announcements through the lens of market intelligence and commercialization. In particular, we will be tracking four streams:
- AI platforms, VLMs, and clinical operating systems
- How vendors present AI and visual language models—as standalone apps, embedded features, or end‑to‑end platforms.
- The evidence, regulatory, and reimbursement narratives behind claims of improved outcomes, efficiency, and burnout reduction.
- Signals that AI is crossing from pilots and proofs‑of‑concept into scaled, enterprise‑level deployments.
- Advanced imaging hardware and precision diagnostics
- Photon‑counting CT, theranostics, high‑field MRI, and other modalities poised to reset expectations on image quality, dose, and diagnostic confidence.
- How OEMs position these systems against existing installed bases and how they articulate ROI to health systems and imaging providers.
- Workflow, workforce, and operational transformation
- Workflow orchestration, remote operations, and automation tools designed to tackle radiologist shortages, burnout, and productivity pressures.
- The degree to which solutions are framed around integrated pathways (from referral to report to follow‑up) versus narrow steps in the workflow.
- Business models, partnerships, and ecosystem plays
- Partnerships between imaging OEMs, AI vendors, and cloud providers; platform bundling strategies; and shifts in pricing / contracting models (e.g., subscriptions, outcomes‑linked pricing).
- Emerging entry points for new players and how incumbents respond with portfolio and GTM moves.
How Marketstrat will cover RSNA 2025
Marketstrat will not be exhibiting at RSNA 2025, but we will be active throughout the meeting as an outside‑in intelligence and commercialization partner.
Our plan includes:
- Daily #RSNA25 signals on LinkedIn
Short, structured posts highlighting 3–4 “signals” each day—tying important announcements or themes back to adoption curves, evidence and reimbursement inflection points, and GTM implications for imaging and AI vendors. - Curated commentary across Industry News & Markintel Pulse
We will track key RSNA press releases, AI Showcase developments, and major product launches, then integrate the most relevant items into our Industry News & Analysis and Markintel Pulse updates, emphasizing the “why it matters” for MedTech and imaging leaders. - A post‑meeting RSNA 2025 strategic recap
After the meeting, we will publish a consolidated RSNA 2025 recap in this Industry Events space—distilling 5–7 strategic signals that should inform 2026+ roadmaps for imaging OEMs, AI vendors, and digital health players. - Targeted debriefs for leadership teams
For teams that want to go deeper, Marketstrat will offer focused post‑RSNA debriefs—linking meeting developments to your specific portfolio, pipeline, and go‑to‑market challenges.
How to engage with Marketstrat during RSNA 2025
If you are attending RSNA in person or following along remotely, there are a few ways to stay connected to our perspective:
- Follow Marketstrat on LinkedIn for daily #RSNA25 signal posts and commentary.
- Subscribe to Markintel Pulse Insights for ongoing weekly briefs on MedTech, imaging, and AI that connect regulatory, evidence, and market moves to concrete next steps.
- Share your RSNA announcements with us or tag Marketstrat so we can incorporate relevant developments into our coverage.
- Contact us if you would like a tailored RSNA 2025 debrief focused on your portfolio, markets, and GTM priorities.
RSNA 2025 is set to be a defining moment for imaging and AI—where precision medicine, inclusivity, workforce realities, and commercial strategy converge. Marketstrat will be tracking the signals, separating hype from durable shifts, and helping leaders translate the meeting’s energy into actionable growth moves for 2026 and beyond.
About Marketstrat
Marketstrat® is a market intelligence and GTM enablement firm committed to empowering clients in data-driven industries. Under the Markintel™ brand, it delivers robust market intelligence, while GrowthEngine solutions offer specialized GTM advisory and app-based tools—together fueling growth, innovation, and competitive advantage. For more information, visit www.marketstrat.com.
Marketstrat® is a registered trademark and Markintel™ is a pending trademark of Marketstrat.
Check out free Research and Insights and Analysis of Industry Events
Check out our collection of Markintel Horizon and Markintel Pulse research.
Check out details on our report, World Market for Oncology Imaging AI
Check out details on our other reports, World Market for AI in Medical Imaging and other Pulse Reports in the Imaging space.
“`